Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Additional Information Regarding RFA-OD-18-001 "Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)" and RFA-OD-18-003 "Tobacco Regulatory Science (R21 Clinical Trial Optional)"
Office of Disease Prevention - Request for Information (RFI): Soliciting Additional Input to the NIH 2018 Tribal Consultation on the Opioid Crisis in Indian Country
National Institutes of Health
Office of Behavioral and Social Science Research - Notice of Clarification of Eligibility for PAR-19-114 "Non-human Primates Facilities to Support HIV/AIDS-related Research (C06) (Clinical Trial Not Allowed)"
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs - Notice of Intent to Publish the Reissuance of RFA-OD-18-002 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences - Notice of Participation of the Office of Research on Womens Health (ORWH) in RFA-DA-19-029, HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34 Clinical Trial Not Allowed) and RFA-DA-19-036, HEAL Initiative: HEA
Office of Research on Women's Health - The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Pacific Regional Workshop on Sexual and Gender Minority (SGM)-Related Research
National Institutes of Health - Notice of OBSSR Participation in RFA-DA-19-034, "HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16-30) Initiative (U24 Clinical Trial Not Allowed)"
Office of Behavioral and Social Science Research - Notice of OBSSR Participation in RFA-DA-19-035, "HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16-30) (UG3/UH3 Clinical Trial Required)"
Office of Behavioral and Social Science Research - Notice of NIAAA's participation in PAR-19-133, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Required)
National Institute on Alcohol Abuse and Alcoholism - Notice of NIAAA's participation in PAR-19-134, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
National Institute on Alcohol Abuse and Alcoholism - Notice of NIAAA's participation in PAR-19-135, Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
(NOT-AA-19-003)
National Institute on Alcohol Abuse and Alcoholism - Notice of NIAAA's participation in NOT-OD-19-040 "Notice of Interest in Long-term Maintenance of Behavior Change Research"
National Institute on Alcohol Abuse and Alcoholism - Notice of Termination of PAR-19-164 "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
National Institute on Alcohol Abuse and Alcoholism - Notice of NIA's Withdrawal from Participation in RFA-DK-18-030, "HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers"
National Institute on Aging - Notice of NIA's Withdrawal from Participation in RFA-DK-18-031, "HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Scientific and Data Research Center"
National Institute on Aging - Notice of Change to Application Types for PAR-18-696, "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)"
National Center for Complementary and Integrative Health - Notice of Pre-Application Webinar for the NIH Consortium for Advancing Research on Botanical and Other Natural Products (CARBON) Program: RFA-AT-19-002, RFA-AT-19-003 and RFA-OD-19-001
National Center for Complementary and Integrative Health
Office of Dietary Supplements - Notice of NIDCD Participation in PA-19-165 "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"
National Institute on Deafness and Other Communication Disorders - Notice of Clarification: Funds Available for RFA-DE-19-008 Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research - Notice of Clarification: Funds Available for RFA-DE-19-009 Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research - Notice of Modifications to Instructions for Letters of Support in PAR-19-102 "Graduate Research Training Initiative for Student Enhancement (RISE) (T32)"
National Institute of General Medical Sciences - Notice of Intent to Publish a Funding Opportunity Announcement for Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Biomedical Imaging and Bioengineering
National Institute of Nursing Research - Notice of Change Application Due Date(s) for RFA-HD-19-024 "Womens HIV Epidemiology Cohort Studies (R01 - Clinical Trial Not Allowed)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Change: Emphasizing Opportunity for Developing Comprehensive Human Genome Sequencing Methodologies in Response to NHGRI Novel Nucleic Acid Sequencing Technology Development FOAs
National Human Genome Research Institute - Notice of NHLBI Participation in PA-19-165 "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"
National Heart, Lung, and Blood Institute - Notice of Data Sharing Policy for the BRAIN Initiative
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Requests for Applications
- Mechanistic studies on chronic alcohol use and sleep homeostasis (R01 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
- HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)
- HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
. - HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
- HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Mental Health
- HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
- Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed)
- Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed)
National Center for Complementary and Integrative Health
Office of Dietary Supplements
- Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
National Cancer Institute
- Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
National Heart, Lung, and Blood Institute
- Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed)
(RFA-MH-20-210)
National Institute of Mental Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Program Announcements
- Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional)
National Heart, Lung, and Blood Institute
Office of Behavioral and Social Science Research
- Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Heart, Lung, and Blood Institute
National Institute on Aging
- Biology of Bladder Cancer (R01 Clinical Trial Optional)
- Biology of Bladder Cancer (R21 Clinical Trial Optional)
National Cancer Institute
- Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu